202 related articles for article (PubMed ID: 12679856)
1. MHC class I-like genes in cattle, MHCLA, with similarity to genes encoding NK cell stimulatory ligands.
Larson JH; Rebeiz MJ; Stiening CM; Windish RL; Beever JE; Lewin HA
Immunogenetics; 2003 Apr; 55(1):16-22. PubMed ID: 12679856
[TBL] [Abstract][Full Text] [Related]
2. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
Cosman D; Müllberg J; Sutherland CL; Chin W; Armitage R; Fanslow W; Kubin M; Chalupny NJ
Immunity; 2001 Feb; 14(2):123-33. PubMed ID: 11239445
[TBL] [Abstract][Full Text] [Related]
3. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
4. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
5. Genomic organization and evolution of the ULBP genes in cattle.
Larson JH; Marron BM; Beever JE; Roe BA; Lewin HA
BMC Genomics; 2006 Sep; 7():227. PubMed ID: 16953885
[TBL] [Abstract][Full Text] [Related]
6. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.
Radosavljevic M; Cuillerier B; Wilson MJ; Clément O; Wicker S; Gilfillan S; Beck S; Trowsdale J; Bahram S
Genomics; 2002 Jan; 79(1):114-23. PubMed ID: 11827464
[TBL] [Abstract][Full Text] [Related]
7. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic analysis of mammalian NKG2D ligand family genes provides insights into their origin and evolution.
Kondo M; Maruoka T; Otsuka N; Kasamatsu J; Fugo K; Hanzawa N; Kasahara M
Immunogenetics; 2010 Jul; 62(7):441-50. PubMed ID: 20376438
[TBL] [Abstract][Full Text] [Related]
9. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
[TBL] [Abstract][Full Text] [Related]
10. ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.
Sutherland CL; Rabinovich B; Chalupny NJ; Brawand P; Miller R; Cosman D
Blood; 2006 Aug; 108(4):1313-9. PubMed ID: 16621962
[TBL] [Abstract][Full Text] [Related]
11. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
Sutherland CL; Chalupny NJ; Cosman D
Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
[TBL] [Abstract][Full Text] [Related]
12. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
13. RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity.
Cao W; Xi X; Hao Z; Li W; Kong Y; Cui L; Ma C; Ba D; He W
J Biol Chem; 2007 Jun; 282(26):18922-8. PubMed ID: 17470428
[TBL] [Abstract][Full Text] [Related]
14. Four novel ULBP splice variants are ligands for human NKG2D.
Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
[TBL] [Abstract][Full Text] [Related]
15. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.
Takada A; Yoshida S; Kajikawa M; Miyatake Y; Tomaru U; Sakai M; Chiba H; Maenaka K; Kohda D; Fugo K; Kasahara M
J Immunol; 2008 Feb; 180(3):1678-85. PubMed ID: 18209064
[TBL] [Abstract][Full Text] [Related]
16. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.
Bacon L; Eagle RA; Meyer M; Easom N; Young NT; Trowsdale J
J Immunol; 2004 Jul; 173(2):1078-84. PubMed ID: 15240696
[TBL] [Abstract][Full Text] [Related]
17. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
[TBL] [Abstract][Full Text] [Related]
18. Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.
Hanaoka N; Kawaguchi T; Horikawa K; Nagakura S; Mitsuya H; Nakakuma H
Blood; 2006 Feb; 107(3):1184-91. PubMed ID: 16195329
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
[TBL] [Abstract][Full Text] [Related]
20. ULBP4 is a novel ligand for human NKG2D.
Chalupny NJ; Sutherland CL; Lawrence WA; Rein-Weston A; Cosman D
Biochem Biophys Res Commun; 2003 May; 305(1):129-35. PubMed ID: 12732206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
